Research Topics
| Paul J MeisSummaryAffiliation: Wake Forest University School of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
The role of 17 alpha-hydroxyprogesterone caproate in the prevention of preterm birthPaul J Meis
Department of Obstetrics and Gynecology, Section of Maternal Fetal Medicine, Wake Forest University Health Sciences, Medical Center Blvd, Winston Salem, NC 27157, USA
Womens Health (Lond Engl) 2:819-24. 2006..Although this drug is not currently commercially available, an application has been made to the US FDA to produce 17 alpha-hydroxyprogesterone caproate, as Gestiva() for the prevention of preterm delivery...- The preterm prediction study: elevated cervical ferritin levels at 22 to 24 weeks of gestation are associated with spontaneous preterm delivery in asymptomatic womenPatrick S Ramsey
National Institute of Child Health and Human Development, Maternal Fetal Medicine Units Network, USA
Am J Obstet Gynecol 186:458-63. 2002..Our objective was to determine whether elevated levels of ferritin in the genital tract may be a potent marker to identify patients at risk for spontaneous preterm delivery... - Progesterone treatment to prevent preterm birthPaul J Meis
Section of Maternal Fetal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA
Clin Obstet Gynecol 47:784-95; discussion 881-2. 2004 - Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproatePaul J Meis
Department of Obstetrics and Gynecology, Wake Forest University, Winston Salem, NC 27157, USA
N Engl J Med 348:2379-85. 2003..The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery... - Does progesterone treatment influence risk factors for recurrent preterm delivery?Paul J Meis
National Institute of Child Health and Human Development, Rockville, Maryland, USA
Obstet Gynecol 106:557-61. 2005..To examine how demographic and pregnancy characteristics can affect the risk of recurrent preterm delivery and the how the effectiveness of progesterone treatment for prevention alters these relationships... - Progesterone treatment to prevent preterm birthPaul J Meis
Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
Drugs 64:2463-74. 2004..Trials of progestogens after the occurrence of symptoms of labour have shown them to be ineffective in prolonging pregnancy... - 17 hydroxyprogesterone for the prevention of preterm deliveryPaul J Meis
Department of Obstetrics and Gynecology, Maternal Fetal Medicine, Winston Salem, North Carolina, USA
Obstet Gynecol 105:1128-35. 2005..Four trials reporting the use of a progestational drug in patients with symptoms of preterm labor found no efficacy in prolonging pregnancy, and the use of 17P or other progestational drugs as tocolytic therapy should not be encouraged... - Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous deliveryCatherine Y Spong
National Institute of Child Health and Human Development, Bethesda, MD, USA
Am J Obstet Gynecol 193:1127-31. 2005..CONCLUSION: 17-OHP caproate therapy given to prevent recurrent PTB is associated with a prolongation of pregnancy overall, and especially for women with a previous spontaneous PTB at <34 weeks... - Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placeboMark A Klebanoff
National Institute of Child Health and Human Development, Bethesda, MD, USA
Am J Obstet Gynecol 199:506.e1-7. 2008.... - Midpregnancy genitourinary tract infection with Chlamydia trachomatis: association with subsequent preterm delivery in women with bacterial vaginosis and Trichomonas vaginalisWilliam W Andrews
Department of Obstetrics and Gynecology, University of Alabama, Birmingham, AL, USA
Am J Obstet Gynecol 194:493-500. 2006..CONCLUSION: In this secondary analysis, midtrimester chlamydia infection was not associated with an increased risk of preterm birth. Treatment of chlamydia was not associated with a decreased frequency of preterm birth... - Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm deliveryBaha Sibai
Department of Obstetrics and Gynecology, University of Cincinnati School of Medicine, Cincinnati, OH 45267, USA
Am J Obstet Gynecol 193:1181-6. 2005..The purpose of this study was to examine the utility of a single second-trimester plasma corticotropin-releasing hormone measurement as a marker for preterm delivery in women at high risk for preterm delivery... - Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birthCynthia Gyamfi-Bannerman
Department of Obstetrics and Gynecology, Columbia University, New York, New York 10032, USA
Obstet Gynecol 119:555-9. 2012..To evaluate whether neonates born to women who previously had received antenatal corticosteroids and then delivered a late-preterm-birth neonate had less respiratory morbidity compared with those not exposed to antenatal corticosteroids... - Timing of elective repeat cesarean delivery at term and neonatal outcomesAlan T N Tita
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Alabama at Birmingham, 619 19th St South, Birmingham, AL 35249, USA
N Engl J Med 360:111-20. 2009..We assessed associations between elective cesarean delivery at term (37 weeks of gestation or longer) but before 39 weeks of gestation and neonatal outcomes... - Perinatal outcomes in women with preterm rupture of membranes between 24 and 32 weeks of gestation and a history of vaginal bleedingMichael D Hnat
Department of Obstetrics and Gynecology, UT Southwestern Medical Center, Dallas, TX 75390 9032, USA
Am J Obstet Gynecol 193:164-8. 2005..The purpose of this study was to compare perinatal outcomes among women with conservatively treated preterm premature rupture of membranes at 24 to 32 weeks of gestation in the presence or absence of vaginal bleeding... - Timing of elective repeat cesarean delivery at term and maternal perioperative outcomesAlan T N Tita
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA
Obstet Gynecol 117:280-6. 2011..We assessed whether delivery before 39 weeks is justifiable on the basis of decreased adverse maternal outcomes... - The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnanciesCynthia Gyamfi
Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
Am J Obstet Gynecol 201:392.e1-5. 2009..To compare the rates of gestational diabetes among women who received serial doses of 17-alpha hydroxyprogesterone caproate vs placebo... - The Preterm Prediction Study: association between maternal body mass index and spontaneous and indicated preterm birthIsrael Hendler
National Institute of Child Health and Human Development, Maternal Fetal Medicine Units Network, National Institutes of Health, Bethesda, MD, USA
Am J Obstet Gynecol 192:882-6. 2005..The purpose of this study was to evaluate the relationship between prepregnancy maternal body mass index and spontaneous preterm birth and indicated preterm birth... - The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomesDwight J Rouse
Department of Obstetrics and Gynecology, Center for Research in Women s Health, University of Alabama at Birmingham, 35249 7333, USA
Am J Obstet Gynecol 191:211-6. 2004..The purpose of this study was to evaluate the relationship between chorioamnionitis and its duration to adverse maternal, fetal, and neonatal outcomes... - Blood transfusion and cesarean deliveryDwight J Rouse
Department of Obstetrics, The University of Alabama at Birmingham, Birmingham, Alabama 35249 7333, USA
Obstet Gynecol 108:891-7. 2006..To evaluate risks for intraoperative or postoperative packed red blood cell transfusion in women who underwent cesarean delivery... - Are women with recurrent spontaneous preterm births different from those without such history?Brian M Mercer
Department of Reproductive Biology, Case Western Reserve University, Cleveland, OH, USA
Am J Obstet Gynecol 194:1176-84; discussion 1184-5. 2006..However, maternal cytokines were not increased with either iSPBs or rSPBs. CONCLUSION: Women with rSPBs are leaner, contract more, have shorter cervixes, and have more advanced Bishop scores than women with iSPBs or rTBs... - The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birthAtef H Moawad
National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Network, USA
Am J Obstet Gynecol 186:990-6. 2002..Elevated corticotropin-releasing hormone levels at 28 weeks are associated with spontaneous preterm birth at <35 weeks... - The NICHD-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcomeBrian M Mercer
NICHD-MFMU Network, Bethesda, MD, USA
Am J Obstet Gynecol 194:438-45. 2006..CONCLUSION: Oligohydramnios should not be a consideration in determining which women will be candidates for expectant management or antibiotic treatment when it is identified at initial assessment of preterm PROM remote from term...